BioRestorative Therapies develops adult stem cell treatments for spine and metabolic conditions and sells a cosmetic skin serum. BRTX reports earnings on Wed, Nov 11, 2026.
Earnings
Earnings calendar →Seasonality
How BRTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.
Whale Options Flow
90DNo whale options trades in BRTX in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BRTX is in one of them and how their past BRTX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BRTX in an article yet. Here's the latest on the wider market.
About BioRestorative Therapies
BioRestorative Therapies develops therapeutic products that use cell and tissue methods, mainly adult stem cells. Its lead candidate is made from a patient's own bone marrow stem cells and is being studied for chronic lower back pain caused by degenerative disc disease and for neck pain, with the aim of offering an option for patients who may otherwise face surgery. The company is also developing metabolic treatments based on stem cells derived from fat, aimed at conditions such as obesity and type 2 diabetes. It sells a skin serum to consumers for fine lines and wrinkles and is based in Melville, New York.
- Headquarters
- Melville, NY